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Hydrothermally processed 1D hydroxyapatite: mechanism of formation and
biocompatibility studies
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Abstract

Recent developments in bone tissue engineering have led to an increased interest in onedimensional (1D) hydroxyapatite (HA) nano- and micro-structures such as wires, ribbons and

AC

tubes. They have been proposed for use as cell substrates, reinforcing phases in composites
and carriers for biologically active substances. Here we demonstrate the synthesis of 1D HA
structures using an optimized, urea-assisted, high-yield hydrothermal batch process. The onepot process, yielding HA structures composed of bundles of ribbons and wires, was typified
by the simultaneous occurrence of a multitude of intermediate reactions, failing to meet the
uniformity criteria over particle morphology and size. To overcome these issues, the
preparation procedure was divided to two stages: dicalcium phosphate platelets synthesized
in the first step were used as a precursor for the synthesis of 1D HA in the second stage.
Despite the elongated particle morphologies, both the precursor and the final product
exhibited excellent biocompatibility and caused no reduction of viability when tested against
osteoblastic MC3T3-E1 cells in 2D culture up to the concentration of 2.6 mg/cm2. X-ray
powder diffraction combined with a range of electron microscopies and laser diffraction
analyses was used to elucidate the formation mechanism and the microstructure of the final
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particles. The two-step synthesis involved a more direct transformation of DCP to 1D HA
with the average diameter of 37 nm and the aspect ratio exceeding 100:1. The comparison of
crystalline domain sizes along different crystallographic directions showed no signs of

T

significant anisotropy, while indicating that individual nanowires are ordered in bundles in
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the b crystallographic direction of the P63/m space group of HA. Intermediate processes, e.g.,
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dehydration of dicalcium phosphate, are critical for the formation of 1D HA alongside other
key aspects of this phase transformation, it must be investigated in more detail in the
continuous design of smart HA micro- and nano-structures with advanced therapeutic
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potentials.
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1. Introduction

The most prospective biocomposites in bone tissue engineering are the combinations
of (a) natural biopolymers as the macroporous matrix phase and (b) inorganic, organic or
hybrid nano- and micro-structures as the reinforcement phase [1–5]. Being the natural bone
mineral phase and being known for an array of properties that favor bone tissue regeneration,
ranging from biocompatibility to osteoconductivity to non-immunogenicity, hydroxyapatite
(HA) is the natural material of choice for the reinforcement phase of biocomposites, rivaled
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in response only by a handful of other biomaterials, such as bioactive glass [6], chitin [7],
carbon/graphene-based nanostructures [8,9], and a few others. A special interest in bone
tissue engineering has been directed to nanoparticulate and nanostructured HA with large
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surface–area–to–volume ratios [10]. Osteoconductivity of the material containing such
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nanostructures is directly dependent on their specific surface area [11], which also favors the
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high loading capacity with respect to various biologically active substances, given that
adsorption presents the sole mechanism of drug loading when it comes to HA. Onedimensional HA nano- and micro-structures for potential biomedical applications, such as

NU

tubes [12,13], wires [14], rods [15–17], ribbons [18] and similar, morphological porous and
hierarchically assembled 3D varieties, are especially good candidates to fulfill these two
demands. The combined effects of nano- and micro-sized surfaces in 1D HA materials could

MA

not only be optimal for cell proliferation and osteogenic differentiation, but also beneficial for
the expression of angiogenetic factors in stem cell differentiation [19]. The development of
procedures for controlled synthesis of 1D HA nanostructures is mainly driven by this goal,

D

especially since the recent progress in this field still does not entirely meet the criteria for

TE

effective control over size and shape.

The first goal of this study was to successfully synthesize uniform 1D HA structures,

CE
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ranging from micro- and nano-wires to micro- and nano-tubes to more complex
morphological varieties, using a hydrothermal batch process on the gram scale. The
framework for the synthesis was adopted by studying the traditional hydrothermal and
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solvothermal methods for the synthesis of 1D HA structures such as whiskers, ribbons,
platelets and tubes [18,20–24] and organic modifiers assisted HA synthesis methods [25–27].
A detailed structural characterization of different intermediates and products of the method
developed herein was then used to clarify the mechanism of the formation of 1D structures.
By examining previous studies concerning the mechanism of 1D HA formation, we have
divided the initially developed one-pot procedure into two stages to achieve a better control
over the product properties. Finally, since uniaxial growth is often accompanied by the less
favorable particle/cell interface, biological assays were conducted to assess the cytotoxicity
and biocompatibility of the synthesized particles in an in vitro setting.

2. Experimental details

2.1. Preparation of HA samples by synthesis path I
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Two synthesis paths were investigated and a two-liter Parr hydrothermal reactor was
used in both of them (Fig.1). The first path was a single-stage, so-called one-pot preparation
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method involving (a) the precipitation of calcium and phosphate ions into dicalcium
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phosphate dihydrate (DCPD, aka brushite) with the addition of urea, and (b) a subsequent
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hydrothermal treatment of the resulting slurry. More specifically, 400 ml 0.12 M calcium
acetate solution in water (Ca(CH3COO)2•H2O, Mw=158.17 g/mol, 99 %, Acros Organics,
Belgium) was added slowly (100 ml/h) to 400 ml 0.1 M solution of ammonium phosphate
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monobasic (NH4H2PO4, Mw=115.03 g/mol, > 98 %, VWR International, USA), under strong
mixing. pH value of the suspension following the addition of calcium acetate was 4.5. After
mixing, 200 ml 0.6 M urea ((NH2)2CO, Mw=60.06, 99 %, Centrohem, Serbia) was added

MA

tothe dispersion and no pH change was detected. The 2 L PTFE liner in which this
suspension had been made was then placed into a 2 L stainless steel cylinder of a Parr
hydrothermal reactor and sealed for the hydrothermal treatment. The synthesis parameters are

D

summarized in Table 1. All syntheses were run at 120 oC and ~ 7 bar pressure without mixing.
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The varied parameters were Ca/P molar ratio (via reducing the Ca content), the hydrothermal

addition.
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reaction time, and polyvinylpyrrolidone (PVP, K30, Mw=40,000 Da, Fluka AG, Switzerland)
Table 1. The hydrothermal synthesis parameters

AC

Ca/P
PVP (g/l)
Hydrothermal
reaction time (h)
pH after the
hydrothermal
reaction

Sample1
1.2
none

Sample2
1.2
none

Sample3
1
None

Sample4
1
2

Sample5
1
none

20

96

20

20

48

9

10

9-10

9

9-10

2.2. Preparation of HA samples by synthesis path II

The second path was composed of two stages and was designed to achieve a better
control of 1D HA structures and help us gain a better insight into the mechanism of 1D HA
formation. The first stage included the preparation of a calcium oleate complex and the
precipitation of dicalcium phosphate anhydrous (DCPA, aka monetite) platelets. This
precursor was then dried (or used freshly prepared) and hydrothermally treated in the second
stage.

ACCEPTED MANUSCRIPT
More specifically, calcium oleate complex was formed by adding 200 ml 0.25 M
water – ethanol (3:7) solution of sodium oleate (CH3(CH2)7CH=CH(CH2)7COONa,
Mw=304.44 g/mol, ≥ 82 % oleic acid content, Sigma – Aldrich, Germany) in 200 ml 0.125 M
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aqueous solution of calcium – nitrate (Ca(NO3)2•4H2O, Mw=236.15 g/mol, ≥ 98 %, Sigma –
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Aldrich, Germany). Precipitated calcium oleate, a white sticky substance, was separated by
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decanting the liquid phase and immediately transferred to a 300 ml flask containing 200 ml
water – ethanol (≈ 1:1) solution of ammonium phosphate monobasic (NH4H2PO4,
Mw=115.03 g/mol, > 98 %, VWR International, USA). Ca/P molar ratio in this stage was set

NU

to 0.5. The flask was then heated and brought to boiling in reflux for 5 h total. The
hydrothermal precursor for Samples 7 and 8 was prepared with the addition of N,N–
dimethylformamide (DMF) (HCON(CH3)2, Mw=73.10 g/mol, ≥ 98 %, Reanal, Hungary) into

MA

the flask three hours into the boiling process. After the completion of the reaction and cooling,
the liquid phase was decanted and the products were repeatedly washed with ethanol,
centrifuged, and left to dry at 60oC overnight. The dried products were placed into a PTFE

D

liner and dispersed by mechanical mixing in 1 L of 0.12 M urea solution. The hydrothermal

TE

reaction was run at 120 oC and 7 bars for 96 h without mixing. The synthesis parameters used
in the making of the DCPA precursor and in the subsequent hydrothermal treatment are

CE
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summarized in Table 2.

Table 2. Parameters describing the synthesis of 1D HA structures in the two-stage process

AC

Precursor
synthesis

Hydrothermal
synthesis

Ca/P
DMF
Drying
Time (h)
pH afterthe
hydrothermal
reaction

Sample6
0.5
none
yes
72

Sample7
0.5
100 ml
yes
72

Sample8
0.5
100 ml
no
72

10

10

10

After the synthesis, the products were collected from the bottom of the liner and
washed with distilled water and centrifuged numerous times. The washing of the samples was
finished at the point when pH of the supernatant was ~ 5.5. The products were then dried for
24 h in an oven at 60 oC. The amount of calcium used in both synthesis routes was the same,
and the mass of the dried products (yield) in each hydrothermal batch was near the
theoretically calculated relative to the calcium content, e.g., 4.5 g for Sample2.
Figure 1. The sketch of ―one-pot‖ route for the synthesis of 1D HAstructures (a), and the two-stage 1D HA
synthesis route via DCP platelets (b).
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2.3. Characterization of samples
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The precursors and products were characterized using X–ray powder diffraction
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(XRD, Philips PW1050 diffractometer with CuKα1,2 radiation), a scanning electron
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microscope (SEM, JEOL JSM 5300), a field-emission SEM (FE – SEM, ULTRA plus, Carl
Zeiss) equipped with an energy-dispersive spectrometer (EDS, Inca 400, Oxford Instruments),
a transmission electron microscope (JEM-2100, JEOL Inc., Tokyo, Japan ), operating at 200

NU

kV and equipped with a slow-scan CCD camera ORIUS SC1000A (Gatan Ltd.), an optical
microscope (B-500MET with Optikam Pro 5LT digital camera, Optika, Italy) and laser
diffraction analyzer (LD, Mastersizer 2000, Malvern Instruments). The ethanol suspensions

MA

of dried precursors and samples used for optical imaging were sonicated for 2 min and
deposited as droplets on slides. Aqueous or ethanol suspensions of dried samples were used
for the LD analysis, depending on the dispersibility of precursors and samples.

D

FTIR spectra were recorded using the KBr pellet technique at the room temperature

TE

on a Nicolet FT-IR 5700 spectrometer (Thermo Electron Corporation, USA) over the 4000–
500 cm−1 wave number range, with 2 cm−1 resolution. Mixtools software package in R
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programming language was used to fit XRD and particle size distribution data. The size
distribution of elongated particles, 1D and 2D structures, analyzed by LD methods appeared
as a mixture of Gaussian distributions [28,29], i.e. a multimodal distribution. The function
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normalmixEM (expectation maximization algorithm) was used to fit the mixtures of
univariate normals. To check how good the fit was, the Kolmogorov – Smirnov test was
performed using an R function ks.test. The sample code, results and cumulative distributions
of experimental and fitted data for DCP platelets are given in the supplementary section. The
distributions were fitted with 2 or 3 Gaussians. The average diameters and aspect ratios of the
synthesized nanowires (n = 91) were determined as a part of the image analysis performed
using ImageJ software (National Institutes of Health, Bethesda, MD).

2.4. Cytotoxicity tests

Mouse calvarial pre-osteoblastic cell line, MC3T3-E1 subclone 4, was purchased
from American Tissue Culture Collection (ATCC, Rockville, MD) and cultured in Alpha
Minimum Essential Medium (α-MEM; Gibco) supplemented with 10% fetal bovine serum

ACCEPTED MANUSCRIPT
(FBS, Invitrogen) and containing no ascorbic acid. The medium was replaced every 48 h, and
the cultures were incubated at 37 oC in a humidified atmosphere containing 5% CO2. Every 7
days, the cells were detached from the surface of the 75 cm2 cell culture flask (Greiner Bio-

T

One) using 0.25 wt% trypsin/EDTA, washed, centrifuged (3000 rpm x 5 min), resuspended in

IP

10 ml media and subcultured in 1:10 volume ratio. To determine if the nanoparticles
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exhibited cytotoxic effects, MC3T3-E1 cells were seeded at 5 x 105 cells/well in 24-well
plates and differentiated into the osteoblastic lineage for 14 days with 100 μg/ml of ascorbic
acid as the chemical differentiation agent dissolved in α-MEM and in the presence of either 1

NU

or 5 mg/well of nanoparticles. Cell viability was determined after 14 days of incubation using
the Vybrant MTT cell proliferation assay (Molecular Probes) and following the
manufacturer’s instructions. Absorbance was read at 570 nm on a UV/Vis spectrophotometric

MA

microplate reader (BGM Labtech, FLUostar Omega). To examine the interaction between
cells and nanoparticles, immunohistochemistry staining was done after 7 days of
differentiation in the presence of nanoparticles. The 5 x 105 cells/well were seeded on glass

D

coverslips, washed with phosphate buffer saline (PBS), and fixed for 5 minutes in 4%

TE

paraformaldehyde. Cells were then washed with PBS and incubated with Alexa Fluor 568
Phalloidin (1:400) (Molecular Probes) and OsteoImageTM bone mineralization staining agent
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(Lonza) for 30 minutes. Cells were then washed 3 times with PBS and cell nuclei were
counterstained using NucBlue fixed cell ReadyProbe reagent (Molecular Probes) for 20
minutes. Images were obtained using a Zeiss LSM 710 confocal microscope (UIC core

AC

imaging facility). All the samples were analyzed in triplicates.

3. Results and discussion

3.1 One pot synthesis of HA nanowires and plates bundles

Preparation of the right precursors is the first and often the most crucial segment of
the hydrothermal synthesis of fine powders. Due to the wide window of chemical parameters
available for control in this stage (salts, complexes, hydroxides, oxides, solvents, et cetera),
various combinations thereof are possible, each leading to a potentially unique product of the
hydrothermal process [30]. The preparation of the precursor calcium phosphate precipitates,
schematized in Fig. 1(a), carried out in an acidic medium (pH ≈ 4.5) and at room temperature,
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in the first synthesis method led to the formation of dicalcium phosphate dehydrate (DCPD)
[31,32], a white flaky precipitate, and could be represented with the following equation:

IP

T

Ca2+ (aq) + H2PO4- (aq) + 2H2O → CaHPO4•2H2O↓ + H+
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With the molar ratio of Ca/P being ≥ 1 (Table 1), H2PO4- ions are expected to be fully
consumed in the process, whereas the release of protons entailing the precipitation reaction
leads to a drop in the pH, down to ~ 4.5. The concentration of OH- ions, i.e. pH, is, in fact,

NU

critical for tuning the composition and morphology of calcium phosphates [32]. During the
treatment, until its complete decomposition, urea provides a source for the steady release of
OH- ions and CO2 at temperatures above 80 oC [21,33]. At the onset of the decomposition,

MA

OH- ions are mostly neutralized by the free protons, which leads to the crystallization of
either DCPD or anhydrous dicalcium phosphate (DCPA), depending on the temperature used
[32,34]. Regardless of the chemical composition, crystal hydrates form at lower temperatures

D

compared to their anhydrous allotropes. This is the result of the large energy barrier

TE

associated with the dehydration process. DCPD, consequently, forms at lower temperatures,
e.g. 50 oC and pH 5, and has a feathery appearance [32]. In contrast, DCPA and
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DCPD/DCPA mixtures form at higher temperatures and with different morphologies,
typically appearing in form of thicker, micrometric plates [34,35]. The formation of DCPA

AC

via dehydration in the hydrothermal solution can be represented as:
CaHPO4•2H2O

CaHPO4 + 2 H2O

Upon the complete consumption of protons from the solution, the concentration of
OH- ions starts to gradually increase and their reaction with DCPD starts, yielding water in
the conversion process. Eventually, if prolonged enough, subjugation to the attack of OHions leads to the dissolution of DCP and recrystallization of HA via a dissolution–
recrystallization mechanism representable by the following equations:
CaHPO4•2H2O (s) + OH- → Ca2+ (aq) + PO43- (aq) + 3H2O
and/or
-

CaHPO4 (s) + OH → Ca2+ (aq) + PO43- (aq) + H2O
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The formation of HA can occur either subsequently, following the dissolution of DCP, or
simultaneously, depending on the kinetic conditions under which urea decomposes:
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T

5 Ca2+ (aq) + 3 PO43- (aq) + OH- (aq) → Ca5(PO4)3OH↓
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Results of the XRD phase analysis of samples synthesized by following the singlestage, ―one pot‖ route are shown in Fig. 2 (a, b). All the reflections in the XRD patterns
match those of the HA reference (AMCSD 0009357) [31]. The comparison of crystalline

NU

domain sizes calculated along different crystallographic directions using Scherrer’s equation
(Appendix A: Supplementary data, Table A1) shows no signs of significant anisotropy of

MA

scattering domains.

Figure 2. XRD patterns of precursor for samples 1 and 2 and for samples from 1 to 5 within the whole 2Θ
measurement range (a) and with a zoom on a selected interval (b). The diffractograms are compared to the

D

reflections of the reference AMCSD code 0008880 and code 0009357 corresponding to DCPD (brushite) and

TE

pure HA, respectively.
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The highest ratio of crystallite sizes, 3.23, corresponding to reflections (002) and
(121), was observed in Sample 2, which consisted of highly elongated particles wrapped up
in bundles (Figs. 3 (a) and A1). However, samples denoted as 1, 3 and 4, consisting of
bundles of thin HA plates (Fig. 3(b), A2(a, b, c), and A3(a, b)), display nearly identical

AC

crystallite sizes for mutually perpendicular, (002) and (300) reflections. For other samples
synthesized using the same, ―one pot‖ method, Samples 2 and 5, this ratio was around 2, the
reason being lower crystallite sizes in the (300) direction in comparison to Samples 1, 3 and 4.
This leads to the conclusion that crystallites forming bundles in Samples 1, 3 and 4,
synthesized at the lowest reaction time (20 h), are ordered in the b crystallographic direction.
By increasing the reaction time to 48 h or 96 h, the bundles disintegrate and 1D HA forms
appear, as observed for Samples 2 and 5 (Fig. 3(b) and (e); Figs. A1, A2(d) and A3(c)). A
considerably lower crystallite size than the longest particle dimensions also confirms the
polycrystalline nature of 1D HA and validates the aggregational growth model now presumed
to apply to all forms of HA, be they biological or synthetic. LD particle size distribution
parameters, including the volumetric mixing proportion (λ), the component median (μ) and
the standard deviation (σ), are shown in Figs. 3 and A3 for all five samples synthesized using
the ―one pot‖ method. The difference in the mixing proportion of a component with the
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smallest median diameter (blue color) indicates that the bundles of platelets disintegrate at
longer reaction times. Only a small fraction of loose particles was detected in Samples 1, 3,
and 4, this may be due to edges and corrugations on bundled plates rather than to loose

T

particles per se. This can explain the difference in μ-s and σ-s of the smallest particle
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component in these five samples.

Figure 3. SEM images of 1D HA along with the particle size distributions for Samples 2 (a) and 4 (b), including
the mixing proportion and other parameters for the convoluted components of the distributions. The μ-s and σ-s

NU

are given in microns. Scale bars are a) 50 and 10 μm and b) 50 and 5 μm respectively.

The formation of plate-like HA structures and their bundles observed in almost all of

MA

the Samples1 – 5 could not be explained by the dissolution–recrystallization mechanism
onlybecause the latter would result in hexagonal, far more uniaxially grown structures that
those evidenced in this case. The crystallization of plate-shaped HA structures thus requires

D

the presence of octacalciumphosphate (OCP) as an intermediate phase. OCP has a layered
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structure composed of alternating apatitic and hydrated layers [36–38]. The layered OCP has
a thin, plate-likemorphology, often resembling ribbons or blades, in contrast to hexagonal HA
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microcrystals, which are usually of needle-shaped character. Yet, the crystal structure of the
apatitic layers in OCP and HA is remarkably similar [39–43]. The conversion of DCP to HAp
via OCP can be represented by the following equations:

AC

8 CaHPO4•H2O + 3H2O → Ca8(HPO4)2(PO4)4•5H2O + 2 H3PO4
Ca8(HPO4)2(PO4)4•5H2O + 3OH- + 2 Ca2+(aq) → Ca10(PO4)6(OH)2 + H+ + 6H2O
Intermediately, hydroxyl groups react with hydrogen phosphates within hydrated OCP layers
to yield phosphates incorporable into the apatite lattice:
HPO42- + OH- → PO43- + H2O
In contrast to the dissolution – recrystallization mechanism, here we have a solid-tosolid conversion. The result is HA of the characteristic morphology, explaining along the way
the evolution of delaminated structures observed in all the samples prepared using the ―one
pot‖ method, especially Samples 1, 3 and 4. The variation of Ca/P ratio and the addition of
PVP in the ranges and amounts tested in this study (Table 1) had no effects on the
morphology. The choice of PVP was justified by its prior association with the uniaxial
growth of HA crystals [44]. The diffractograms and optical micrographs of the one–pot
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precursor of Samples 1 and 2 are shown in Fig. 2(a, b) and Fig. A6(a), respectively. The
precursor is identified as DCPD (brushite) and exhibits an irregular plate-like morphology.
The obvious change in the morphology en route from the precursors to the products in the

T

one-pot synthesis indicates that the dominant formation mechanism is dissolution –
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formation of irregular plate–like particles in Samples 1 – 5.

IP

recrystallization. Still, solid state conversion could not be excluded as a mechanism of

The complexity of the transformation mechanisms observed in this system and its
relative insusceptibility to morphological control called for a more simplistic approach in the

NU

synthesis of the desired, 1D morphological structures. The partitioning of synthesis stages
came out as one of the solutions.

MA

3.2 Two stage synthesis of HA nanowires via DCPA precursor

The first step of this modified, two-stage synthesis procedure (Fig. 1 (b)) belongs to

D

the synthesis of DCPA precursors via hydrolysis of calcium oleate in a water–ethanol
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solution. Ethanol is used to increase the solubility of calcium oleate, a compound fairly
soluble in hot ethanol, but practically insoluble in water. The precipitation of DCPA can be
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described in this case with the following reactions:
H2PO4- ↔ H+ + HPO42-
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Ca(OL)2 + 2H+ ↔ Ca2+ + 2OLH

Ca2+ + HPO42- + 2H2O → CaHPO4•2H2O↓
CaHPO4•2H2O

CaHPO4 + 2 H2O

where OL- is the oleate anion, CH3(CH2)7CH=CH(CH2)7COO-, and OLH is the oleic acid, a
product of the hydrolysis reaction.

Figure 4. XRD patterns of the precursors for the hydrothermal synthesis of HA following the second, two-step
route (a) for the whole 2Θ measurement range and (b) with a zoom on a selected interval. The star (*) denotes
an unidentified impurity in sample 6 (b). The patterns are compared with the reference cards for brushite –
DCPD code no. 0008880 [45] and monetite – DCPA code no. 0009584 [46].
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Figure 4 shows XRD patterns of the precursor powders following drying in an oven at
o

60 C for one day. Interestingly, all powders converted to HA, demonstrating the transient
stability of DCPA. Micrographs of the precursor powders shown in Fig. 5, most importantly,

T

show the lamination of platelets. All the precursor samples contained platelets with a lamellar
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substructure, being the results of the specific growth habit typical for DCPA crystals. Then,
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the (-1 2 0) reflection in the precursor for Sample 7, prepared with the addition of DMF, is
distinctively more intense than the one in the precursor for Sample 6, prepared using the same
parameters but excluding DMF. Sample 7 was also synthesized using different precursor

NU

concentrations so as to investigate the previously suggested influence of DMF on
crystallization of calcium phosphates [35] and is shown as supplementary data. The
mechanism for this effect has not been elucidated yet, but has been exploited in ―one pot‖

MA

solvothermal syntheses of different 1D and 2D forms of HA [35]. Although the use of DMF
does induce a structural change in synthesized DCPA, all of the precursors synthesized in its
presence had the same morphology (Fig. A4). Another effect that plays a crucial role in

D

ensuring the growth of regularly shaped platelets comes from oleic complexes as

TE

Ca2+concentration buffers as well as of oleic anions as agents for the directed, face-specific
growth. Namely, as the oleic anion, OL-, tends to form a complex bond with Ca2+, crystal

CE
P

planes terminated with the largest density of Ca2+ ions will tend to exhibit the largest
inhibition of growth.

AC

Figure 5. SEM and TEM images of platelets as precursors for the hydrothermal synthesis of Samples 6 (a)
(scale bars 1 μm and 500 nm) and 7 (b) (scale bars 1 μm, 500 nm and 200 nm), revealing laminated
microstructure.

Dried precursors were used for the synthesis of HA Samples 6 and 7, while Sample 8
was hydrothermally synthesized using a freshly made and washed, but not dried, precursor
otherwise identical to that of Sample 7. The difference in the crystallite size between these
samples, as shown in Table A1, was insignificant. All the samples were identified as HA,
with only a slight difference in the diffraction peak intensity ratios (Fig. 6).
Figure 6. XRD patterns of Samples 6, 7 and 8 compared to the reference AMCSD code 0009357 corresponding
to pure HA.
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Morphologically, however, the samples were very different, as seen from the
corresponding SEM images (Fig. A5). Thus, Sample 6 consists of fine needle–like particles,
oftentimes arranged in ladders or woven platelets (Figs. 7 and A5(a)). Sample 7 consists of
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long wires with up to 10 μm in length and around 30 nm in diameter, having the aspect ratio

IP

of over 100:1 (Fig. 8). The morphology of particles comprising Sample 8 is slightly different
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from those found in Sample 6. It is characterized by a small extent of disintegration, the result
of which are particles with retained plate-like morphology, but with brush-like ends (Fig. A5

NU

(c)).

Figure 7. FE-SEM, TEM images and electron diffractions of Samples 6 (a) (scale bars 200 nm) and 7 (b) (scale

MA

bars 200 and 50 nm). SAED patterns are identified as HA reflections.

Morphological changes associated with the transformation of DCPA to HA were
observed and discussed in the literature. The predominant transformation, accompanying the

D

dehydration of DCPD, is thought to involve the formation of splinters, which then transition

TE

to nanorods and nanofibers, transforming along the way to HA [23,35], though the one
involving OCP as the intermediate phase appears to be equally prominent [47]. Both

CE
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mechanisms assume that the preserved morphology of the precursor is due to the similarity of
the crystal structures of DCPA and OCP to HA. Again, ribbon–like morphologies are
typically attributable to the transformation via OCP, whereas DCPA tends to dissolve and

AC

form splinters which regrow into elongated 1D shapes and eventually rearrange into
hierarchically ordered structures. In this study we have come up with a clear evidence of the
effect that the structural changes of DCPA precursors have on the morphology of the
resulting HA particles. Under all the conditions tested for the hydrothermal transformation of
DCPA into 1D HA structures, the complete conversion of shapes occurredin one case only
(Sample 7).

Figure 8. Distribution of the diameters and lengths of HA nanowires comprising Sample 7, resulting from the
comparative analysis of several TEM and optical microscopy images. The mean diameter and length of HA
nanowires are 37 nm and 3.7 microns respecively.

The

mechanism

for

the

formation

of

uniform

1D

HA

structures

is

dissolution/recrystallization, kinetically limited and controlled by the gradual solubility of
DCPA as the intermediate and the source of ions for the growth HA. Whereas abrupt
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increases in supersaturation favor the formation of rounded and smaller particles, slow
increases in supersaturation favor the elongation of HA crystals, alongside excluding the
epitaxial growth of HA on an OCP template in the form of plates [21]. Urea decomposition is

T

one factor enabling the slow release of a constitutive ion, OH-, and its concentration can be

IP

tuned by controlling the temperature of the hydrothermal treatment, i.e. temperature at which
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urea decomposes. Another factor, equally critical, is the intermediate dissolution of DCPA.
For example, if the surface of DCP is blocked with oleic species, the dissolution is hindered
and non-uniform growth results. The precise coupling of the two simultaneously occurring

NU

processes - dissolution/recrystalization and solid–to–solid conversion – appears to be crucial
in order to obtain elongated and uniform morphologies. The presence of OCP, that occurs as
an intermediary in the one-pot synthesis, can be used as an indicator that the transformation

MA

of DCP to HA is not direct enough and not optimized to yield 1D structures. Thus we believe
that controlling the concentration of OH- ions throughout the growth process in a specific,
relatively narrow range is a key factor in favor of the growth of 1D structures. It can be tuned

D

by controlling the temperature of the hydrothermal process (mainly in lower and mild
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temperature ranges) and the amount of urea as the source of OH- ions.
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3.3 FTIR analysis of precursors and samples
The FTIR spectra of the DCPD precursor for Samples 1 and 2, of Ca oleate complex,
and of the DCPA precursors for Samples 6 – 8, along with the corresponding final products,
are shown in Fig. 9. Based on the FTIR spectrum of the one-pot synthesis precursor, Fig. 9

AC

(a), it is identified as pure DCPD [48,49] (purple line). The spectra of precursors used in the
second, two-stage synthetic approach (Samples 6 – 8) are identified as DCPA (green and
black lines) and are shown along with the IR spectrum of calcium oleate complex (blue line).
The prominent bands at 2923 cm-1 and 2852 cm-1 correspond to the asymmetric and
symmetric stretch of -CH2- groups. The characteristic doublet at 1577 cm-1 and 1541 cm-1,
together with the bands at 1467 cm-1 and 1429 cm-1, is assigned to the asymmetric and
symmetric stretch of -COO- groups [50,51]. The given bands are characteristic for calcium
oleate (calcium dioleate) complex. The DCPA precursors have characteristic bands
originating from P-O- and P-O-H bonds at 1131 cm-1, 1067 cm-1, 902 cm-1, 578 cm-1 and 530
cm-1. The band at 1637 cm-1 results from the H-O-H bending and rotation of the residual
water, while bands at 2923 cm-1 and 2852 cm-1 are attributed to –CH2– groups from oleate
anions adsorbed on the surface of monetite. Distinct bands arise in the precursor of Sample 6,
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specifically at 1707 cm-1 and 1736 cm-1, corresponding to adsorbed oleic acid dimer and
monomer, respectively [52]. This specific band does not exist in the spectrum of the
precursor for Samples 7 and 8. This might be the effect of hydrolysis of oleate at lower pH
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values during the reaction to which DMF is not added. The addition of DMF raises pH of the

IP

reaction medium and prevents the hydrolysis of oleate anion and its conversion to oleic acid
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[53]. FTIR spectra of HA samples contain all four characteristic apatite phosphate vibration
modes with bands at 1094 cm-1, 1031 cm-1, 961 cm-1, 602 cm-1 and 564 cm-1 [54].

NU

Figure 9. FTIR spectra of precursors for the hydrothermal synthesis of HA (a) and of the products (Samples 2, 6,
7, 8) (b).

From these characterization data, we can conclude that two key factors play a role in

MA

determining the final morphology of HA samples synthesized using the two-stage method.
The first is the adsorption of oleic species and the second is the drying of the freshly
synthesized precursor. In the case of the adsorption of oleic acid, presumably in bilayers, as

D

we assume it occurs on the DMF-free precursor of Sample 6, it must entail a significant

TE

change of surface hydrophilicity. Specifically, the surface becomes more hydrophobic, which
slows down the kinetics of dissolution. Sample 6 is morphologically different from Sample 8,
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in a way that platelets appear more disintegrated, albeit not fully. Dissolution was more
intense than in Sample 8, but less than in Sample 7. The formation of HA nanowires observed
in all three samples can be attributed to the presence of oleate ion, which is capable of

AC

binding more intensely to Ca2+ on the surface of HA;this would explain the more directed and
uniaxial growth of HA. As for the second effect, the drying of the precursor, we believe that
low temperature transformation, physical or chemical, may occur, e.g., dehydration of DCPD
to DCPA and/or desorption of oleate species. One must notice that the characterized
precursors were dried at 60 oC for 24 h. Sample 8 is prepared using a freshly synthesized
precursor without the drying step during which we believe the solid–to–solid chemical
reaction is promoted; as a result, the plate-like morphology is being predominantly retained.
These intermediate processes, alongside other key aspects of this phase transformation, must
be investigated in more detail in the design of HA micro- and nano-structures with advanced
therapeutic potentials.

3.4 In vitro study of synthesized DCPA platelets and HA nanowires

ACCEPTED MANUSCRIPT
Cytotoxicity and biocompatibility of DCPA platelets as precursorsfor HA nanowires
comprising Sample 7, as well as of the given HA nanowires,were examined in vitro, in
osteoblastic MC3T3-E1 cell culture. The MTT assay measures the mitochondrial succinic

T

dehydrogenase activity and is a strong indicator of cytotoxic effects affecting cell viability.
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Elongated particle morphologies are often associated with increased cytotoxicity, even for
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compositions for which round particle shapes have no adverse effects on cells. Although
tremolite [55] and other asbestoses [56] are paradigmatic examples in favor of this effect, the
latter has been observed for multiple other particle compositions, ranging from titania [57] to

NU

carbon nanotubes [58] to ceria [59]. Moreover, compared to spherical HA nanoparticles,
needle-shaped ones induced a considerably higher cytotoxicity and inflammatory cytokines
production in BEAS-2B and RAW264.7 cells than the spherical ones [60]. Apoptosis

MA

mediated by a mitochondrial-dependent pathway in primary rat osteoblasts was also
noticeably increased following incubation with needle-shaped HA particles as opposed to the
spherical ones [61]. Such apoptotic effects observedin HepG2 cells were the basis for

D

proposing HA as utilizable in the treatment of hepatoma and other types of cancer [62].
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Needle-shaped HA also slowed down the cell metabolism and inhibited hatching in catfish Tcells and zebrafish embryos in a dose-dependent manner [63]. Other studies suggested good
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biocompatibility and a lack of cytotoxic effects of needle-shaped HA when tested in vitro
[64,65], demonstrating a great degree of variability of the biological response to such
morphologies. The exact amount, shape, texture, aspect ratio, surface charge, agglomeration

AC

degree, the dosage mode (seeding cells onto the powder, depositing powder on top of the
cells or co-seeding), the cell type and the interaction of the particles with biomolecules
contained in the growth medium are all factors influencing the biological response to them,
needing further studies to be discerned and analyzed. As seen in Fig. 10, no decrease in cell
viability was observed for any of the three calcium phosphate samples (spherical HA
standard, needle-shaped HA comprising Sample 7, and DCPA as the precursor for Sample 7)
in comparison with the particle-free control. The only significant difference in viability was
observed for the spherical HA nanoparticle standard synthesized using a previously reported
protocol [66]: cells incubated with this powder demonstrated a higher viability compared to
the control, particle-free cell population, albeit only at the lower of the two tested particle
concentrations (Fig.10). Also, the elongated HA particles comprising Sample 7 did not cause
any significant change in cell viability compared to the spherical HA nanoparticle standard at
either of the two particle concentrations. These results corroborate our previous finding of no
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markedly negative effects on osteoblastic cells exerted by elongated particles of DCPA
synthesized in an urea-assisted precipitation process except for the mild granulations of the
cytoskeletal microfilaments [67]. In spite of the dosage amount exceeding fifty times that for

T

which apoptotic effects were observed in osteoblasts in an earlier study [61] (0.02 – 1 vs. 1 –

IP

5 mg/ml), no inhibitory effects or cellular injury were detected for 1D HA fabricated in this
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study.

Figure 10. MTT assay absorbance indicative of the viability ofosteoblastic MC3T3-E1 cells incubated with
various calcium phosphate powders at the concentrations of 0.5 and 2.6 mg/cm2 (1 and 5 mg per well and per ml

NU

of media in the standard 24-well plate, respectively). All the data are represented as averages of three
independent cell/particle analyses. Error bars represent the standard deviation (for Sample 7 HA at 5 mg/ml it is
invisible to the eye). Data points significantly different from the ―cell only‖ control (p < 0.05) are marked with

MA

an asterisk.

Concordantly, immunofluorescent images shown in Fig. 11 demonstrate a favorable

D

particle/cell interface for both the DCPA precursor and the final product, HA, of Sample 7.

TE

Cytoskeletal f-actin microfilaments display a continuous, uninterrupted structure, devoid of
aggregations, signifying a healthy internal structure and morphology of the cells in contact

CE
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with the particles. No difference between the control, particle-free cell populations and those
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incubated with these two types of elongated particles of calcium phosphate was observed.

Figure 11. Confocal optical micrographs of MC3T3-E1 cells incubated either with identical amounts (5 mg/well)
of Sample 7 HA particles (a) or Sample 7 precursor DCPA particles (b) and culturedfor 7 days. Green – calcium
phosphate particles; blue – MC3T3-E1 cell nuclei; red – f-actin cytoskeletal microfilaments.

4. Conclusion

In summary, we designed a two-stage process for the high-yield synthesis of 1D HA
nanostructures with diameters on the nano scale and aspect ratios exceeding 100:1.
Optimization of the DCP precursor for the hydrothermal synthesis is required for its
transformation to 1D HA to reach completion. To achieve a better control over particle size
and morphology, the first stage of the process, involving the synthesis of DCP, must be
investigated in more detail. Understanding the effect of various hydrothermal processing

ACCEPTED MANUSCRIPT
parameters, to which this study has contributed, will help in gaining a better control over this
process and making it more suitable for the application as a method for the high-yield
synthesis of various other 1D HA micro- and nano-structures. In vitro studies on osteoblastic

T

cells demonstrated the absence of any cytotoxic effects caused by the particles and a very

IP

high level of biocompatibility, indicating a pronouncedly promising potential of these HA

SC
R

systems for biomedical applications.
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